Impella-Induced Incessant Ventricular Tachycardia

Area of Science:

• Cardiology
• Medical Devices
• Critical Care Medicine

Background:

• Impella 2.5 and Impella Cardiac Power (CP) devices offer mechanical circulatory support for high-risk procedures and cardiogenic shock.
• These devices are vital as a bridge to recovery or destination therapy.
• Clinical and hemodynamic assessments are critical for determining Impella device indication in cardiogenic shock.

Observation:

• A 62-year-old male with cardiogenic shock required Impella device support.
• Two days post-implantation, the patient experienced incessant ventricular tachycardia.
• Transthoracic echocardiography revealed Impella device migration from the ventricular cavity.

Findings:

• Ventricular tachycardia resolved immediately after repositioning the Impella device.
• The study highlights a direct correlation between device migration and arrhythmia development.

Implications:

• This case underscores the necessity of imaging modalities like transthoracic echocardiography for verifying Impella device placement.
• Accurate positioning within the left ventricle is essential to prevent serious complications such as ventricular tachycardia.
• Routine echocardiographic monitoring can enhance patient safety during Impella support.